By University of Louisville School of Medicine –
A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health.
The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for heart failure and the first to use intravenous (IV) delivery of cell therapy for heart failure. It is the first trial in the world to test multiple doses of stem cell therapy for chronic heart failure.
